Selected Publications
Fesnak AD, Raval JS: Adverse Events of Cellular and Biotherapies AABB Technical Manual, 21st edition (in press) : 2023.
Fesnak AD, Siegel DL: Chimeric antigen receptor T cells and other cellular immunotherapies Rossi's Principles of Transfusion Medicine, Sixth Edition : 2022.
Guleria I, de Los Angeles Muñiz M, Wilgo M, Bapat A, Cui W, Hsu YS, Jeyaraman M, Muthu S, Rodriguez F, Fesnak A, Celluzzi C, Sesok-Pizzini D, Reich-Slotky R, Spitzer T.: How do I: Evaluate the safety and legitimacy of unproven cellular therapies? Transfusion 62 (3): 518-532,2022.
Frey NV, Gill S, Hwang WT, Luger SM, Martin ME, McCurdy, SR, Loren AW, Pratz KW, Perl AE, Barber-Rotenberg J, Marshall A, Ruella M, Lacey SF, Fraietta J, Fesnak A, O'brien M, Schanne T, Brogdon JL, Engels B, Levine BL, June CH, Porter DL, Hexner EO: CART22-65s Co-Administered with huCART19 in Adult Patients with Relapsed or Refractory ALL Blood 138 (Supplement 1): 469,2021.
Bar KJ, Shaw PA, Choi GH, Aqui N, Fesnak A, Yang JB, Soto-Calderon H, Grajales L, Starr, J, Andronov M, Mastellone M, Amonu C, Feret G, DeMarshall M, Buchanan M, Caturla M, Gordon J, Wanicur A, Monroy MA, Mampe F, Lindemuth E, Gouma S, Mullin AM, Barilla H, Pronina A, Irwin L, Thomas R, Eichinger RA, Demuth F, Luning Prak ET, Pascual JL, Short W, Elovitz MA, Baron J, Meyer NJ, Degnan KO, Frank I, Hensley S, Siegel DL, Tebas P: A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia J Clin Invest 131 (24): 2021.
Myers RM, Li Y, Barz Leahy A, Barrett DM, Teachey DT, Callahan C, Fasano CC, Rheingold SR, DiNofia A, Wray L, Aplenc R, Baniewicz D, Liu H, Shaw PA, Pequignot E, Getz KD, Brogdon JL, Fesnak AD, Siegel DL, Davis MM, Bartoszek C, Lacey SF, Hexner EO, Chew A, Wertheim GB, Levine BL, June CH, Grupp SA, Maude SL: Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia J Clin Oncol 39 (27): 3044-3055,2021.
Abou-el-Enein M, Elsallab M, Feldman SA, Fesnak AD, Heslop HE, Marks P, Till BG, Bauer G, SavoldoB: Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy Blood Cancer Discov 2 (5): 408-422,2021.
Brennan AL, Guilliams J, Fox E, Carreno B, Linette G, Levine BL, Plesa G, Siegel D, Mackey S, Fesnak A: Discussion of the requirements, challenges and processing adaptations involved in an academic technology transfer of neo-antigen peptide pulsed peptide pulsed dendritic cells Cytotherapy 23 (5): S173-S173,2021.
Golden RJ, Fesnak AD: Clinical development of natural killer cells expressing chimeric antigen receptors Transfus Apher Sci 60 (1): 103065,2021.
Gladney W, Jadlowsky J, Davis MM, Fesnak A: CAR T Cells: A Novel Biological Drug Class Successful Drug Discovery : 159-198,2021.
View all publications
Academic Contact Information
3400 Spruce Street
3 Ravdin Building - R3067
Philadelphia,
PA
19104
Phone: 215-662-3325